J&J pays $8.9 billion to settle claims that beauty talc merchandise prompted most cancers
Containers of Johnson’s baby powder, manufactured by Johnson and Johnson, are displayed on a shelf July 13, 2018 in San Francisco, California.
Justin Sullivan | Getty Images
Johnson&Johnson on Tuesday said it would pay $8.9 billion over the next 25 years to settle allegations that the company’s baby powder and other talc products caused cancer.
The company proposed the settlement in a securities filing.
But J&J still pushed back on the Talk allegations.
“The Company continues to believe these allegations are flimsy and lack scientific merit,” Erik Haas, J&J’s global vice president of litigation, said in a statement.
The company stopped selling its talc-based baby powder worldwide in 2023 after facing thousands of lawsuits from customers claiming its talc products caused cancer due to contamination with a carcinogen called asbestos.
J&J spun off subsidiary LTL Management in October 2021 to reduce its litigation and settlement losses. The company referred its Talk lawsuits to the subsidiary and declared it bankrupt.
This is breaking news. Please check back for updates.
Comments are closed.